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Because of the emergence of Buruli ulcer disease, the
World Health Organization launched a Global Buruli Ulcer
Initiative in 1998. This indolent skin infection is caused by
Mycobacterium ulcerans. During a study of risk factors for
the disease in Ghana, adequate excisional skin-biopsy
specimens were obtained from 124 clinically suspicious
lesions. Buruli ulcer disease was diagnosed in 78 lesions
since acid-fast bacilli (AFB) were found by histopathologic
examination. Lesions with other diagnoses included filaria-
sis (3 cases), zygomycosis (2 cases), ulcerative squamous
cell carcinomas (2 cases), keratin cyst (1 case), and lymph
node (1 case). Thirty-seven specimens that did not show
AFB were considered suspected Buruli ulcer disease
cases. Necrosis of subcutaneous tissues and dermal colla-
gen were found more frequently in AFB-positive specimens
compared with specimens from suspected case-patients
(p<0.001). Defining histologic criteria for a diagnosis of
Buruli ulcer disease is of clinical and public health impor-
tance since it would allow earlier treatment, leading to less
deforming sequelae.
M
ycobacterium ulcerans produces an indolent cuta-
neous infection known as Buruli ulcer disease (1–4).
Three clinical stages of lesions have been described: preul-
cerative (which can present as a nodule, papule, plaque, or
edema), ulcerative, and healed (scar) disease (5). The clin-
ical characteristics of these lesions are nonspecific, partic-
ularly during the preulcerative stage. Lesions usually start
as a single, painless, subcutaneous nodule, ill-defined
edema, or plaque that enlarges over time. The skin that
covers the nodule or plaque eventually sloughs off, togeth-
er with the underlying tissues, forming an ulcer. If left
untreated, the ulcer enlarges and becomes undermined.
The patient usually has no systemic symptoms.
Spontaneous healing of the ulcer has been described; heal-
ing starts at the proximal end of the ulcer and extends to
the distal portions, resulting in a depressed scar that con-
tracts and may produce severe deformities (1). 
Many diseases can be confused with Buruli ulcer dis-
ease in each of its clinical stages; thus, laboratory tests and
procedures can help establish the diagnosis (4). Such
methods include culturing for M. ulcerans from lesion
samples, testing swab samples of ulcers for acid-fast bacil-
li (AFB), histopathologic screening for characteristics of
the disease, using polymerase chain reaction (PCR) to find
bacterial DNA; or all of the above (3–7). Of the previous-
ly enumerated methods, only culture can be considered
specific for detection of M. ulcerans, but it has a low sen-
sitivity (3–5). Several authors have described the
histopathologic changes of Buruli ulcer disease as the
patients progress through the different clinical stages (8,9).
However, letting a patient progress to a diagnostic ulcer is
unacceptable. Thus, better defining diagnostic histopatho-
logic features, particularly in the early stages, is of clinical
and public health importance since this will allow early
treatment and lead to less deforming sequelae. 
M. ulcerans has been identified in many tropical and
temperate parts of the world, and in the last decade reports
of the disease have increased in several West African coun-
tries, including Ghana (3,10). As part of a study of surveil-
lance, serodiagnosis, and identification of risk factors for
Buruli ulcer disease in Ghana, excisional skin-biopsy spec-
imens were obtained from clinically suspect lesions. We
review the histopathologic examination of the skin speci-
mens from the patients from Ghana and list the differential
diagnoses encountered in preulcerative and ulcerative
lesions. We compare the histopathologic features of AFB-
positive and AFB-negative specimens and correlate patho-
logic examination, PCR, and culture results.
Materials and Methods
A total of 144 excisional skin-biopsy specimens were
obtained from patients with clinically suspect lesions at
therapeutic centers of excellence for Buruli ulcer disease in
three highly disease-endemic districts in Ghana.
Specimens were fixed in formalin and transported to the
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Representative portions of the specimens, measuring about
2.5 x 1.5 x 0.5 cm, were embedded in paraffin in one cas-
sette, and sections were stained with hematoxylin and
eosin (H&E) and Ziehl-Neelsen (to highlight AFB). Table
1 describes the histopathologic features evaluated. One
pathologist (JG) searched for AFB, using the 40X magni-
fication objective through the entire section (each slide
was reviewed for 45 to 60 min). When a section did not
have AFB bacilli, additional tissue specimens with approx-
imately the same dimensions as the first were embedded in
paraffin and studied with H&E and Ziehl-Neelsen stains.
In AFB-negative cases, fungal causes of nodules and
ulcers were searched by using Grocott methenamine silver.
Cases in which the specimen lacked subcutaneous adi-
pose tissue were excluded from analysis. Specimens in
which AFB were found in histologic sections were consid-
ered definite cases; specimens with negative AFB were
considered suspected cases unless they had other diag-
noses that could account for a clinical nodule or ulcer.
Confirmation of histopathologic diagnosis of Buruli ulcer
disease was possible in 62 cases by using culture, PCR for
M. ulcerans, or both. Culture and PCR (IS2404) were per-
formed according to standard techniques (4,11). Complete
details of these techniques and a comparison of diagnostic
methods will be published separately.
The frequency of diagnosis of nodules versus diagnosis
of ulcers was determined. The histopathologic features of
AFB-positive specimens compared to such features in
AFB-negative specimens, and definite Buruli ulcer disease
preulcerative lesions compared to ulcerative lesions were
derived with SAS 8.2 (SAS Institute, Inc., Cary, NC) by
using the chi-square and Fisher exact tests with a statisti-
cal significance of p=0.05. The same statistical tools were
used to analyze frequencies of the histopathologic features
in AFB-negative versus confirmed cases. 
Results
Adequate material for histopathologic review was
available for 124 of 144 cases. Twenty cases (14%) were
excluded because of lack of subcutaneous tissue in the
biopsy specimen. The results of analysis of these 124 spec-
imens are shown in Table 2. In summary, using histopatho-
logic methods, we evaluated 30 (24%) nodules, 6 (5%)
plaques, and 88 (71%) ulcers. By histopathologic exami-
nation, diagnoses other than Buruli ulcer disease were
found for nine patients, seven of whom had nodules and
two of whom had ulcers. Patients with nodules included
three with parasites (two Onchocerca volvulus and one
Mansonella streptocerca), two with deep fungi (subcuta-
neous zygomycosis), one with a keratin cyst, and one with
a hyperplastic lymph node; the two patients with ulcers
had squamous cell carcinoma. AFB were present in 78
(63%) specimens, while 37 (30%) specimens did not have
AFB and were considered suspected cases of Buruli ulcer
disease. Of 78 cases with positive AFB, bacilli were found
in 69 (88%) of the first specimens submitted for pathology
and 9 (11%) when additional tissue (available in 48 of the
original AFB-negative specimens) was studied. We had a
histopathologic diagnosis in 25 (83%) of the 30 nodules,
whether this was definite Buruli ulcer disease or another
diagnosis; the proportion of pathology diagnosis was
lower for ulcers (57 [65%] of 88). The proportion of nod-
ules and ulcers with a definite diagnosis of Buruli ulcer
disease was approximately the same (60% vs. 62%).
The histopathologic features for AFB-positive and
AFB-negative cases are shown in Table 3. Necrosis of the
subcutaneous tissues was found in 100% of AFB-positive
and 62% of AFB-negative cases (p<0.001). Sixty-one per-
cent of AFB-positive cases and 6% of AFB-negative cases
had necrotic collagen in the dermis (elastolysis) (p<0.001).
In 92% of AFB-positive cases, the inflammatory infiltrate
had neutrophils mixed with mononuclear cells; by con-
trast, suspected cases had a predominance of mononuclear
inflammation (p=0.008). Epidermal hyperplasia (either
psoriasiform or pseudoepitheliomatous), chronic and gran-
ulomatous inflammation, and vasculopathy were found at
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Table 1. Histopathologic features evaluated in definitive and suspected 
Buruli ulcer cases 
Location, feature  Comments 
Epidermis    
Hyperplasia  Psoriasiform (regular downward elongation 
of rete ridges), or pseudoepitheliomatous 
(irregular elongation of rete ridges) 
AFB
a  Presence or absence 
Dermis    
Elastolysis  Collagen degeneration and necrosis seen as 
granular blue/purple collagen bundles with 
H&E stain 
Inflammation, type  Acute (presence of neutrophils), chronic 
(presence of lymphocytes and 
macrophages), or granulomatous (presence 
of multinucleated giant cells and epithelioid 
histiocytes) 
AFB  Presence or absence 
Vascular changes  Thickening of the media, necrosis, and 
inflammation of vascular walls 
Subcutis     
Necrosis  Coagulative or fat necrosis 
Inflammation, type  Acute (presence of neutrophils), chronic 
(presence of lymphocytes and 
macrophages), or granulomatous (presence 
of multinucleated giant cells and epithelioid 
histiocytes) 
Inflammation, intensity  Absent, mild (scattered inflammatory cells), 
or intense (inflammation forming nodules or 
bands) 
AFB  Absent, mild (1–5 AFB seen with 40X 
objective), moderate (>6 AFB seen with 
40X objective), or marked (AFB seen with 
20X objective as clumps or colonies) 
aH&E, hematoxylin and eosin stain; AFB, acid-fast bacilli. approximately the same rate for both AFB-positive and -
negative cases. Duration of the lesion was available for
113 cases; 70 were positive for AFB, 35 were negative, and
8 had other diagnoses. Forty-seven (67%) AFB-positive
cases had lesions that had been present for <3 months, with
a median of 2 months (range 0.2–36); for AFB-negative
cases, 19 (54%) had lesions that were present <3months,
with a median of 3 months (range 0.2–156) (p=0.64). 
The frequency of the histopathologic variables for
preulcerative and ulcerative stage of AFB-positive cases is
shown in Table 4. Variables that showed significant asso-
ciation with the ulcerative stage included epidermal hyper-
plasia (p=0.005), intense chronic inflammation (p=0.013),
and granulomas (p=0.005). Dermal elastolysis was more
frequent in preulcerative lesions (p=0.015). Of note is the
lack of a statistically significant difference between preul-
cerative and ulcerative lesions for the concentration of
AFB in the subcutaneous tissues (p=0.07). Psoriasiform
epidermal hyperplasia was found in 47 Buruli ulcer disease
cases, 7 in preulcerative lesions and 40 in ulcers.
Pseudoepitheliomatous hyperplasia was found in 27 cases,
3 with preulcerative lesions and 24 with ulcers. AFB in the
keratin were found in one nodule and in seven ulcer cases.
Figure 1 shows a photomicrograph of a nodule, and Figure
2 shows an ulcer from a definitive case.
Of the 37 AFB-negative cases, 1 had a positive culture,
and 22 had M. ulcerans nucleic acids detected by PCR.
However, positive PCR results were also obtained from
samples of cases with filarial nodules (three patients), ker-
atin cyst, deep fungi, and squamous cell carcinoma (one
patient each). Analysis of hsitopathologic features showed
a significant association of necrosis of subcutaneous tis-
sues and elastolysis (p=0.0009 and p<0.0001, respective-
ly) with confirmed cases compared to AFB-, culture-, and
PCR-negative cases. 
Discussion
Necrosis of subcutaneous tissues and dermal collagen
accompanied by minimal inflammation and AFB are con-
sidered the most reliable histopathologic features for the
diagnosis of Buruli ulcer disease (8,9,12). Our study
demonstrated that necrosis of both the subcutis and dermal
collagen was significantly associated with cases. The
necrosis found in such cases has been attributed to a
polyketide (called mycolactone) that is produced by M.
ulcerans and acts as an extracellular toxin (13–16). AFB-
positive cases showed a significant association with the
presence of neutrophils mixed in the necrotic material. In
Buruli ulcer disease cases, inflammation appears to be
minor for the amount of necrosis, which accounts for pre-
vious descriptions of minimal inflammatory response.
Possibly, the toxin that induces adipose cell necrosis also
induces necrosis of the inflammatory infiltrate.
Several authors have established that during the preul-
cerative stage and early in the ulcerative stage, the coagu-
lative necrosis forms a nidus where calcifications and AFB
colonies are easily visualized (8,9,12,17). However, when
the ulcer starts healing, and granulation tissue, fibrosis,
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Table 2. Number (percent) of specimens with other diagnoses, definite, and suspected Buruli ulcer according to clinical stage
a
Clinical stage  Other diagnoses  Definite BU (AFB positive)  Suspect BU (AFB negative)  Total 
Nodule  7 (6)  18 (14)  5 (4)  30 (24) 
Plaque  0  5 (4)  1 (0.8)  6 (5) 
Ulcer  2 (1.6)  55 (44)  31 (25)  88 (71) 
Total  9 (7)  78 (63)  37 (30)  124 (100) 
aBU, Buruli ulcer; AFB, acid-fast bacilli. 
Table 3. Comparison of histopathologic features of definite and suspected Buruli ulcer cases 
Histopathologic feature  Buruli ulcer (AFB positive)
a no. (%)  Suspected Buruli ulcer (AFB negative)
a no. (%)  p value 
Epidermis
b        
Hyperplasia  50/73 (68)  21/35 (60)  0.38 
Dermis
b       
Elastolysis  45/74 (61)  2/35 (6)  <0.0001 
Subcutaneous tissue       
Necrosis   78/78 (100)  23/37 (62)  <0.0001 
Vasculopathy  58/78 (74)  27/37 (73)  0.87 
Acute inflammation
c  72/78 (92)  27/37 (73)  0.008 
Chronic inflammation
d  31/78 (40)  18/37 (49)  0.36 
Granulomas
e  30/78 (38)  12/37 (32)  0.53 
aAFB, acid-fast bacilli.
 
bSeven specimens did not have epidermis, and six did not have dermis.
 
cAcute inflammation considered as present versus absent. 
dChronic inflammation considered as intense versus mild. 
eGranulomas considered as present versus absent. and granulomatous inflammation are present, AFB are dif-
ficult to document (8,9,17). Our study showed AFB in the
keratin layer in seven of the Buruli ulcer disease ulcer
cases and only in one nodule. AFB in keratin have been
observed previously and may represent bacilli from
colonies that are actively being sloughed off or they may
be carry over from histologic processing (8). Contrary to
findings in published reports, our study did not show a sta-
tistically significant difference in the amount of AFB in the
subcutaneous tissues in the preulcerative and ulcerative
stages. Additionally, the presence of AFB in clinically sus-
pect lesions was not related to the duration of the lesion.
These findings can be explained by any or all of the fol-
lowing factors: our study had a small number of cases in
the preulcerative stage; our sampling techniques were
geared to maximizing the amounts of AFB in the tissues
(AFB have been observed more frequently in the distal
portion of the ulcer); we obtained lesion samples at an ear-
lier stage than other researchers. In addition, previous stud-
ies have not used statistical methods to analyze the fre-
quency of histopathologic features; thus, the interpretation
of results has been subjective. 
Our study showed that epidermal hyperplasia and
chronic inflammation with formation of granulomas were
statistically more frequent in Buruli ulcers than in preul-
cerative lesions. All these features have been described to
be more prominent in the later stages of disease (8,9).
Epidermal regeneration occurs in an effort to cover the epi-
dermal tissue defect (18). In our cases, the most frequent
type of regeneration was psoriasiform, with some case-
patients exhibiting pseudoepitheliomatous hyperplasia.
Granulomatous inflammation is characteristic of persistent
infections that evoke delayed hypersensitivity, as seen in
several mycobacterial and fungal infections. Some authors
have suggested that leprosy and Buruli ulcer disease may
have similar gradation of the inflammatory process from
foamy macrophages (lepromatous) to well-formed granu-
lomas (tuberculoid) (9,19).
Currently, confirmation of clinically suspected cases of
Buruli ulcer disease is based on culture of M. ulcerans
from the tissues, presence of AFB in swab samples, evi-
dence of M. ulcerans DNA, or characteristic histopatho-
logic changes in tissue sections (3,4). Several problems are
evident from this manner of confirming a diagnosis. The
isolation rate of M. ulcerans from patients approaches only
35% because the bacteria are very difficult to culture (20).
In our series, only one suspected case was confirmed by
using culture. AFB in swab samples are rare and depend on
the clinical stage and tissue sampled (3,4,8,20). None of
the cases in this cohort was confirmed by AFB in swab
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Table 4. Comparison of histopathologic features of preulcerative and ulcerative lesions in definite Buruli ulcer cases 
Histopathologic feature  Preulcerative no. (%)  Ulcerative no. (%)  p value 
Epidermis
       
Hyperplasia
a  8 (42)  42 (78)  0.005 
Dermis
       
Elastolysis
a  17 (85)  28(52)  0.015 
AFB in dermis
b  8 (40)  10 (19)  0.34 
Subcutaneous tissue          
AFB in subcutis
c  18 (78)  31 (56)  0.074 
Acute inflammation
d  22 (96)  50 (91)  0.48 
Chronic inflammation
e  4 (17)  27 (49)  0.013 
Granulomas
f  3 (13)  27 (49)  0.005 
aTwo specimens did not have epidermis, and one did not have dermis.
 
bConsidered as presence of acid-fast bacili (AFB) in dermis.
 
cConsidered as intense versus mild AFB in subcutis.
 
dAcute inflammation considered as present versus absent. 
eChronic inflammation considered as intense versus mild. 
fGranulomas considered as present versus absent. 
Figure 1. a, Hematoxylin and eosin stain of a lesion specimen
showing definitive Buruli ulcer disease in the preulcerative stage
(original magnification 50x). Notice the psoriasiform epidermal
hyperplasia (H), superficial dermal lichenoid inflammatory infiltrate
(I), and necrosis of subcutaneous tissues (N). b, Ziehl-Neelsen
stain of the same nodule, showing abundant colonies of acid-fast
bacilli in the necrotic subcutaneous tissues (original magnification
100x).specimens. PCR would conceivably be helpful, but no data
are available on sensitivity and specificity with large num-
bers of clinical specimens (5,11). In this cohort, PCR
showed positive results in cases with filarial nodules and a
keratin cyst; since these patients had single nodules and
did not have histopathologic evidence of Buruli ulcer dis-
ease, the findings probably represent false-positive PCR
results. The cases with positive PCR results and squamous
cell carcinoma and deep fungi could potentially have either
two concomitant infections or a cancer arising from long-
standing Buruli ulcer disease (21). Issues of DNAcontam-
ination, required technical expertise, and PCR costs pro-
hibit this assay’s utility as a routine clinical diagnostic tool
in the field (3,5,13,14).
“Characteristic” histopathologic changes are consid-
ered one of the confirmatory laboratory methods for Buruli
ulcer disease; however, the features are nonspecific and
change as the lesion evolves from a nodule to an ulcer. In
this study, definite histopathologic diagnosis of Buruli
ulcer disease was only possible in 63% of cases because
the presence of AFB bacilli was not always detectable even
though necrosis of subcutaneous tissue and collagen were
observed. An additional challenge in the histopathologic
diagnosis of this disease is having adequate tissue samples.
In our study, 14% of the specimens were considered inad-
equate because they lacked subcutaneous tissue, and
among those with adequate material, 11% required addi-
tional tissue to demonstrate AFB. New techniques that can
be applied to tissue are greatly needed to diagnose Buruli
ulcer disease in all stages. Until these techniques are avail-
able, defining diagnostic histopathologic features of the
disease will enable better understanding of clinicopatho-
logic and pathogenetic characteristics of M. ulcerans
infection. 
For this study, we collected samples from more ulcers
than nodules; however, a higher proportion of nodule spec-
imens received a histopathologic diagnosis. The
histopathologic differential diagnosis for ulcers included
squamous cell carcinomas only; among the other clinical
diagnoses that can be encountered in this stage are tropical
phagedemic ulcer, actinomycosis, noma, leishmaniasis,
yaws, and scrofuloderma (4). In our cohort, the histopatho-
logic differential diagnosis for nodules was more extensive
and included other infectious diseases (filaria and zygomy-
cosis) as well as other noninfectious causes of skin nodules
(keratin cyst) (4). 
In summary, our study shows the histopathologic fea-
tures of patients with clinically suspected Buruli ulcer dis-
ease in a population with a high prevalence of the disease.
We found that necrosis of subcutaneous tissues and dermal
collagen was the best predictor of disease; however, the
histopathologic changes are not unique, and diagnosis
requires correlation with the clinical picture and other lab-
oratory techniques. 
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